Targeting the Transforming Growth FactorB Signaling Pathway in Human Cancer

The TGF-β signaling pathway offers many different avenues for therapeutic intervention, each of which offers advantages and drawbacks. Current therapeutic approaches for modulating TGF-β signaling involve antagonism of TGF-β ligand binding to the heteromeric receptor complex with isoform-selective antibodies as large molecule inhibitors, such as metelimumab (for TGF-β2) and lerdelimumab (for TGF-β2/3) from Genzyme, and pan-TGF-β antibodies such as GC-1008 (Genzyme), ID-11 (Genzyme), SR-2F (NCI/NIH) and 2G7 (Genentech) antibodies, or soluble TGFβRII receptor fusion proteins (Biogen). Alternatively, the intracellular inhibition of the TGFβRI kinase can be achieved with small molecule inhibitors, such as SB431542 and SB505124 from GlaxoSmithKline; LY580276, LY550410, LY364947, LY573636 and LY2157299 from Eli Lilly; SD093 and SD208 from Scios. Other inhibitors for TGF-β receptor kinase are NPC30345 (Scios), Ki-26894 (Kirin brewery), SM16, A-83-01 (Kyoto Pharma), SX-007 (Scios) and IN-1130 (In2Gen), and dual inhibitors of both the TGFβRI and TGFβRII kinases, such as LY2109761 (Eli Lilly). Alternatively, expression of TGF-β isoforms can be affected by antisense technology targeting mRNA sequence-specific degradation, such as AP-12009 and AP-11014 which were developed by Antisense Pharma and targeted to TGFβII and TGFβI, respectively. SIS3 is a selective chemical inhibitor of Smad3 activation and Smad3-mediated DNA binding and gene expression.
Targeting the Transforming Growth FactorB Signaling Pathway in Human Cancer

Publication

Targeting the Transforming Growth Factor-β Signaling Pathway in Human Cancer. () Nagathihalli S Nagaraj, et al. Expert Opin Investig Drugs. ;19(1):77-91. Figure: F2.

Gene mentions


Organism Group Word Match Source NCBI Symbol NCBI ID
Homo sapiens Primates TGF-B TGFB ncbigene_synonym TGFB1 7040
Homo sapiens Primates TGF-B TGFB famplex_relations TGFB2 7042
Homo sapiens Primates TGF-B TGFB famplex_relations TGFB3 7043
Homo sapiens Primates 2G7 2G7 ncbigene_synonym LINC01150 101927624
Homo sapiens Primates TGFBRI TGFBR1 ncbigene_symbol TGFBR1 7046
Homo sapiens Primates TGFBRII TGFBRII ncbigene_synonym TGFBR2 7048
Homo sapiens Primates Smad2 SMAD2 ncbigene_symbol SMAD2 4087
Homo sapiens Primates Smad3 SMAD3 ncbigene_symbol SMAD3 4088
Homo sapiens Primates Smad7 SMAD7 ncbigene_symbol SMAD7 4092
Homo sapiens Primates Smad4 SMAD4 ncbigene_symbol SMAD4 4089

Chemical mentions

Word Match MeSH Name ChEBI
SB431542 SB 431542 mesh:C459179 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide chebi:91108
SB505124 NA mesh:C519132
LY364947 LY 364947 mesh:C520284 Ly-364947 chebi:91198
LY2109761 NA mesh:C530108
LY573636 NA mesh:C534068
LY2157299 LY-2157299 mesh:C557799 LY-2157299 chebi:137064

Disease mentions

Word Match MeSH Name DOID